2014 - Enseval Putera Megatrading Tbk

COMPANY UPDATE
PT ENSEVAL PUTERA MEGATRADING TBK.
Ended September 30, 2014 (Unaudited)
Passion For Excellence:
The Journey to Excellence
TABLE OF CONTENT
SECTION 1
Enseval In Brief
3
SECTION 2
Business Overview
8
SECTION 3
Operational Overview
20
SECTION 4
Financial Overview
23
SECTION 5
2014 Overview
28
SECTION 1
ENSEVAL IN BRIEF
ENSEVAL IN BRIEF
Integrated healthcare Distribution and Logistic services company through Service Excellence, Technology
Driven and Strong Leadership.



4
Established in October 1973 with the aim of managing the distribution function because of the
separation of the distribution division from the marketing and production division of PT Kalbe
Farma;
On 1 August 1994, the Company listed its shares on the Jakarta Stock Exchange;
The Company focuses its activities on distribution and trading services under 5 divisions :
 Pharmaceutical products sales and distribution, which comprised of patented medicines as well
as generic medicines;
 Consumer products, non prescription medicine and nutrition sales and distribution;
 Medical equipment sales and distribution, which include marketing activities;
 Raw material sales and distribution, which include veterinary product;
 Healthcare services.
ENSEVAL IN BRIEF
More than 40 years in business, Enseval constanly makes the best effort to obtain sustainable growth.
5
1993 – PT Arya Gupta
Cempaka changed its name to
PT
Enseval
Putera
Megatrading
1973 – Incorporation
of PT Enseval
1988 – Incorporation
of PT Arya Gupta
Cempaka
2003 – Incorporation
of
PT
Millenia
Dharma Insani
2007 – Incorporation of PT
Enseval Medika Prima and
PT
Global
Chemindo
Megatrading
2012 – Obtained ISO
9001:2008
certification
2013 – Makassar, Bandung and Bekasi
awarded – BPOM awards these centres for
Good
Distribution
Practice
in
Pharmaceuticals.
2008 – Incorporation of PT
Renalmed Tiara Utama
1994 – PT Enseval Putera
Megatrading Tbk conducted
its Initial Public Offering
2011 – The Company
Right Issue to finance
expansion
2014 - Bogor, Jember, Jakarta 1, Jakarta 2,
Palembang, Balikpapan, Kupang, Palu, Padang,
& Pematangsiantar awarded – BPOM awards
these centres for Good Distribution Practice in
Pharmaceuticals.
ENSEVAL IN BRIEF
Become Market Leader Through high quality of information Technology system and competent human
resources.




6
Currently, the Company owns and operates 45 branches and 24 branches under subsidiaries, and 21
sales office located throughtout in Indonesia;
The Company also owns 2 Regional Distribution Center (RDC) located in Jakarta and Surabaya;
For the information technology platform, the Company now is using Oracle E-Business Suite Release
12;
Until the end of september 2014, the Company's operation supported by over than 6,500
employees.
2014 OVERVIEW
Award & Sertification Until September 2014
• ORACLE - EXA Trend-Setter Award.
• FRONTIER - The Best Building and Managing Corporate Image.
• FROST & SULLIVAN - Indonesia Pharmaceutical Distributor of the year.
• Department of Animal Husbandry in East Java province - the best distributor of veterinary drug.
• HERMINA HOSPITAL GROUP - The Best Pharmaceutical Distributor.
• NIVEA - The Best Weighted Distributor.
• Rekor Bisnis Indonesia - Pharmaceutical Distributor with the Most Outlet Coverage.
• The Most Powerful Distribution Performance
– EXTRA JOSS
– KOMIX
7
2014 OVERVIEW
Award & Sertification Until Sept 2014
• AZ/NZS ISO 9001:2008 Certified
• BS OHSAS 18001:2007 Certified
• Good Distribution Practices Certified
• Cara Distribusi Obat yang Baik (CDOB Certified)
8
SECTION 2
BUSINESS OVERVIEW
BUSINESS OVERVIEW
Net Sales per Products until September 30, 2014
*Description of net sales per products as describe below :
Products Portfolio
Net Sales (Rp)
Consumer Products
5.605.279.741.614
44,91%
Prescription Medicines
3.530.569.712.145
28,29%
Non Prescription Medicines
1.935.481.406.595
15,51%
Raw Materials
980.416.817.219
7,86%
Medical devices
389.362.725.464
3,12%
Veterinary Products
34.805.551.047
0,28%
Health Care Services
4.027.913.464
0,03%
12.479.943.867.548
100%
Total :
10
Contribution to Total Net
Sales
BUSINESS OVERVIEW
Description of Net Sales per Products and The Contribution
7,86%
3,12%
0,28%
0,03%
Consumer Products
Prescription Medicines
Non Prescription Medicines
Raw Materials
Medical devices
Veterinary Products
Health Care Services
15,51%
28,29%
11
44,91%
Net Sales
September 2014
Rp12,479.9 billion
BUSINESS OVERVIEW
All Business Line of the company were grew significantly
*Growth of net sales per products as describe below :
Products Portfolio
Net Sales Sept 2013 (Rp)
Net Sales Sept 2014 (Rp)
Growth
Consumer Products
4,876,545,566,749
5,605,279,741,614
14.94%
Prescription Medicines
3,187,925,237,275
3,530,569,712,145
10.75%
Non Prescription Medicines
1,793,538,025,206
1,935,481,406,595
7.91%
Raw Materials
785,571,592,382
980,416,817,219
24.80%
Medical devices
479,026,292,974
389,362,725,464
-18.72%
Veterinary Products
30,998,375,025
34,805,551,047
12.28%
Health Care Services
2,991,698,813
4,027,913,464
34.64%
11,156,596,788,424
12,479,943,867,548
11.86%
Total :
12
BUSINESS OVERVIEW
Growth of Net Sales 2013 vs 2014
11.86 %
2013
2014
14.94 %
10.75 %
7.91 %
24.80 %
Total Net
Sales
13
Consumer
Products
Prescription
Medicines
Non
Raw Materials
Prescription
Medicines
-18.72 %
12.28 %
Medical
Devices
Veterinary
Products
34.64 %
Health Care
Services
BUSINESS OVERVIEW
The Company’s Principals
Prescription
Non-Prescription
Consumer Health
14
BUSINESS OVERVIEW
The Company’s Principals
Medical Device & Diagnostic
15
BUSINESS OVERVIEW
The Company’s Principals
Raw material
16
BUSINESS OVERVIEW
National Coverage 65 Full Services Branches & More than 200,000 Direct Outlet Coverage
RDC JAKARTA
RDC SURABAYA
45 BRANCH
24 BRANCH under subsidiaries (TSJ)
21 SALES OFFICE
BUSINESS OVERVIEW
More than 200,000 direct outlet coverage
Type of outlet coveraged by the company’s distribution
Covers all trade channels in the market :
General / Traditional
Trade Channel
• Wholesalers
• Retailers
• Provision Stores
• Convenience Stores
• Food & Beverage
• Store - Fruit Shops
• Cosmetic Stores
• etc
18
Modern Trade Channel
• Hypermarkets
• Supermarkets
• Mini Markets
• Departement Stores
• etc
Pharmaceutical Trade
Channel
• Pharmacies
• Drugstores
• Hospitals
• Labs – Clinics
• Institutions
• etc
2014 OVERVIEW
Sales Contribution by Channel (Sept 2013 vs Sept 2014)
2013
Pharmaceutical Trade
Modern Trade
2014
General Trade
Pharmaceutical Trade
Modern Trade
23,80%
27,97%
36,65%
40,37%
31,66%
19
General Trade
39,55%
2014 OVERVIEW
Sales Contribution by Principal (Sept 2013 vs Sept 2014)
2013
External Principal
2014
Internal Principal
External Principal
Internal Principal
21%
33%
67%
79%
20
BUSINESS OVERVIEW
The Company’s modern trade account
21
BUSINESS OVERVIEW
200,000+ Direct Outlet Coverage
Covers all trade channels in the market:
- General / Traditional Trade Channel:
Wholesalers, Retailers, Provision
Stores, Convenience Stores, Food &
Beverage Stores, Fruit Shops,
Cosmetics Stores, etc
- Modern Trade Channel:
Hypermarkets, Supermarkets, Mini
Markets, Department Stores, etc
- Ethical Trade Channel: Pharmacies,
Drugstores, Hospitals, Labs - Clinics,
Institutions, etc
F&B Stores; 15.000
Cosmetics; 1.750
Others; 9.800
Provision Store; 162.000
Pharmacy; 11.571
Hospital; 1.614
Drugstore; 4.485
Wholesaler; 2.260
Hypermarket, 178
Supermarket; 1.179
Minimarket; 3.115
22
SECTION 3
OPERATIONAL OVERVIEW
OPERATIONAL OVERVIEW
Mobile application (Tablet Computer & PDA)
- Supervisor: Team Performance Analysis
- Salesman & Deliveryman: Faster Order Taking & Faster Information Process
Global Information System (GIS)
- Application for more in depth sales and territory mapping .
Supported by Enseval Customer Care (ECC)
- in Branches Order Management, Complaint Handling, Basic Product Information .
Customers also can reach Enseval office via Phone, Fax & Email for easy customer ordering.
24
OPERATIONAL OVERVIEW
IT Infrastructure
Centralized IT system using Oracle E-Business Solutions
• Integrated & Real Time system
Use the best world-class ERP system by Oracle
Complete Oracle E-Business Suite
Oracle Warehouse Management System (WMS)
Advance Supply Chain Planning (ASCP) and Oracle Demantra
Tablet Computer & PDA system E-Mobile ®
2,300+ PDA used by Supervisors, Salesmen, Deliverymen, & Collectors
Menu: Distribution Plan, Distribution Achievement, Overdue, etc
Provide data security for antivirus by Trend Micro and Sonic Wall
25
OPERATIONAL OVERVIEW
Comprehensive Business Access
• ENI (Enseval Net Info)
•
•
Web based application
Sales (hourly updated) & Stock (D-1)
• EXI (Enseval Xpress Info)
•
•
SMS based application
Sales & Stock Report
For Principal
• ERI (Enseval Raw Data Info)
•
Raw Data format, distribution and logistics information activities
• ENO (Enseval NET Order)
•
26
Online order with business-to-business system
For Customer
SECTION 4
FINANCIAL OVERVIEW
FINANCIAL OVERVIEW
Net Sales Growth
Net Sales
2013
2014
COGS
88.97%
- 0.17%
88.80%
11,86%
11.65%
11.156,60
30 Sept 2013
(Unaudited)
28
12.479,94
30 Sept 2014
(Unaudited)
9.926,43
30 Sept 2013
(Unaudited)
11.082,39
30 Sept 2014
(Unaudited)
: Net Sales 30 Sept 2013 in Rp/billion
: COGS 30 Sept 2013 in Rp/billion
: Net Sales 30 Sept 2014 in Rp/billion
: COGS 30 Sept 2014 in Rp/billion
: COGS Margin
FINANCIAL OVERVIEW
Expense Ratio
Gross Profit
0.17%
Operational Expense
11.20%
11.03%
13.61%
0.09%
7.43%
13.20%
938,86
1.397,55
1.230,16
30 Sept 2013
(Unaudited)
829,34
30 Sept 2014
(Unaudited)
Gross Profit (Rp/Billion)
Gross Profit Margin
29
7.52%
30 Sept 2013
(Unaudited)
30 Sept 2014
(Unaudited)
Operational Expense (Rp/Billion)
Operational Expense Margin
FINANCIAL OVERVIEW
Profit Growth (Sept 2013 vs Sept 2014)
Income Before Tax Expense
Operating Profit
3.59%
0.09%
3.68%
14.44%
3.52%
0.33%
3.85%
Income For The Year
2.60%
0.24%
2.84%
22.17%
22.34%
400,82
458,69
30 Sept 2013 30 Sept 2014
(Unaudited)
(Unaudited)
Operating Profit
(Rp/Billion)
Operating Profit Margin
30
393,13
480,27
30 Sept 2013 30 Sept 2014
(Unaudited)
(Unaudited)
290,21
355,04
30 Sept 2013 30 Sept 2014
(Unaudited)
(Unaudited)
Income Before Tax Expense
(Rp/Billion)
Income Before Tax Expense
Margin
Income For The Year Margin
FINANCIAL OVERVIEW
Financial Position (December 2013 vs Sept 2014)
8.63%
11.68%
4.91%
5.528,07
6.005,12
2.489,22
31 Dec 2013 30 Sept 2014
(Audited)
(Unaudited)
Total Assets (Rp/Billion)
31
2.611,46
31 Dec 2013 30 Sept 2014
(Audited)
(Unaudited)
Total Liabilities (Rp/Billion)
3.038,85
3.393,67
31 Dec 2013 30 Sept 2014
(Audited)
(Unaudited)
SECTION 5
2014 OVERVIEW
Warehouse Management System
-Oracle-based WMS
-Manage stock from
inbound-outbound,
by location, SKU, Batch Number,
Expiry Date
-Bar-coding system with mobile bar-code reader
to eliminate duplication & increase accurate
operation
Cold Chain Management
-Enseval has implemented and Standardized Cold Chain Management in it’s
RDC, Branch Warehouse, and Transportation according to ISO 9001:2008.
-Cold Chain Management is performed with close control
-All activities is always recorded and stored properly
Cold Chain Handling in Enseval
Delivery with
Temperature Controlled Transportation
Temperature Monitoring
Document
Standardized Facilities
Standardized Branches (Full Services)
Strategic Value to Business Partners
Market Leading Position in
Indonesia
• Strong product portfolio.
• Sustainable business growth.
• Supported by 2 RDC, 45 branches, 21 Sales Office, & 200,000+ direct coverage outlets.
• 40+ years of strategic expertise in distribution and logistics service.
Reliable Partner to Grow
Transparency and Neutrality
• Strong and good relationship with all business players : Principals & Outlets.
• Having in aggregate over 100 years of experience senior management team and supported by more than 5000
employees.
• Public listed company with professional management that treats all business partners equally with the utmost
transparency and accountability.
• Independent business entity with neutrality to ensure fairness to all stakeholders.
Strong Financial Track Record
Enseval’s Commitment Towards
Improvement
• Robust balance sheet figures.
• Solid financial performance.
• Commitment to assist & support Principal to achieve it’s goals.
• Implementation of Continuous Improvement (CONIM) in all business aspects by Enseval’s employees in every
level.
FORWARD LOOKING STATEMENT
This presentation has been prepared for informational purposes only by PT Enseval Putera Megatrading Tbk. ("Enseval" or the "Company")
This presentation has been prepared solely for use in connection with the release 0f 30 Sept 2013 unaudited results of the Company. The information contained
in this presentation has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to, and no reliance should
be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein. None of the Company or any of their
respective affiliates, and their respective commissioners, directors and employees, advisors or representative shall have any liability whatsoever (in negligence
or otherwise) for any loss however arising from any use of this presentation or its contents or otherwise arising in connection with the presentation. Any
decision to purchase or subscribe for securities of the Company should not be made on the basis of the information contained in this presentation.
The presentation is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an
exemption from registration.
This presentation and its contents are confidential unless they are become generally avaiable as public information in accordance with prevailing laws
regulations (other than as a result of a disclosure by you) and must not be distributed, published or reproduced (in whole or in part) or disclosed by receipents
to any other person. This presentation does not constitute a recommendation regarding the securities of the Company.
This presentation, including the information and opinions contained herein, is provided as the date of this presentation and is subject to change without notice,
including change as a result of the issuance of 30 Sept 2013 unaudited results of the Company.
This presentation includes "forward-looking statements". These statements contain the words "anticipate", "believe", "intend", "estimate", "expect" and words
of similiar meaning. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding the
Company's financial position, business strategy, plans and objectives of management for future operations (including development plans, objectives relating to
the Company's products and services and anticipated product launches) are forward-looking statements. Such forward-looking statements are based on
numerous assumptions regarding the Company's present and future business strategies and the environment in which of the Company will operate in the
future. These forward-looking statements speak only ast the date of this presentation. The Company expressly disclaims any obligation or reflection of any
change in the Company's expectations with regard thereto, or any change in events, conditions or circumtances on which any statements is based.
Market data and certain industry forecast used in this presentation were obtained from market research, publicity avaiable information and industry
publications which have not been independently verified, and no presentation is made as to the accuracy of such information.
THANK YOU
For Further Information:
Corporate Secretary
PT Enseval Putera Megatrading Tbk.
Enseval Building
Kawasan Industri Pulogadung
Jalan Pulolentut No. 10
Jakarta 13920 – Indonesia
Phone : 62-21-46822422 Fax : 62-21-4609039
Website : www.enseval.com
Email : investor.relations@enseval.com